A Clinical Investigation Evaluating Peristeen® Performance

NATerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

January 1, 2024

Study Completion Date

February 13, 2024

Conditions
Neurogenic Bowel
Interventions
DEVICE

Peristeen

The Peristeen system will be handled by Coloplast trained personnel. The investigator and a trained nurse will participate in all the investigation related procedures. The nurse is trained in the handling of the investi-gational product as well as this is described in detail in the Instruction for Use (IFU). Subjects (and their caregivers, if appropriate) will also be trained on the use of Peristeen prior to independent use at home.

Trial Locations (1)

28204

Atrium Health, Charlotte

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Coloplast A/S

INDUSTRY